Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.

Abstract	During the screening of samples obtained from 5 individuals with type III hyperlipidemia, we identified a variant of apolipoprotein (apo) E which exhibited a discrepancy in apo E phenotype showing the E3/E1 isoform on isoelectric focusing (IEF) analysis and E3/E3 on gene analysis. Sequence analysis of the DNA of the proband that was amplified by PCR and subcloned, revealed a single substitution of one lysine (AAG) for one glutamic acid (GAG) at position 146, thereby adding two negatively charged units to apo E3. This defect had been described only for apo E1 to date (Mann et al. (1989) Clin. Res. 37, 520A (abstract)). In this case, PCR-mediated site-directed mutagenesis was used to identify the structural alterations forming the abnormal E1 genotype in the proband's family. Purified apo E1 Lys-146----Glu showed less than 10% of binding activity to apo B, E receptor on human skin fibroblasts compared with apo E3. This substitution demonstrates that Lys-146 is essential for the binding of apo E to the receptor.
Authors	K Moriyama, J Sasaki, A Matsunaga, F Arakawa, Y Takada, K Araki, S Kaneko, K Arakawa
Journal	Biochimica et biophysica acta (Biochim Biophys Acta) Vol. 1128 Issue 1 Pg. 58-64 (Sep 22 1992) ISSN: 0006-3002 [Print] Netherlands
PMID	1356443 (Publication Type: Case Reports, Journal Article)
Chemical References	Apolipoprotein E2 Apolipoproteins E Glutamates Oligodeoxyribonucleotides Glutamic Acid DNA Lysine
Topics	Adult Amino Acid Sequence Apolipoprotein E2 Apolipoproteins E (blood, genetics, isolation & purification) Base Sequence Child DNA (blood, genetics, isolation & purification) Electrophoresis, Gel, Two-Dimensional Female Genetic Carrier Screening Glutamates Glutamic Acid Humans Hyperlipoproteinemia Type III (blood, genetics) Lysine Male Middle Aged Molecular Sequence Data Oligodeoxyribonucleotides Pedigree Polymerase Chain Reaction (methods) Polymorphism, Restriction Fragment Length

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!